Brown Fat Activity and White Fat Accumulation
Study Details
Study Description
Brief Summary
White and brown adipocytes differ in their expression of hormones, cytokines, and inflammatory factors, and they modulate different biological functions. While white adipose tissue (WAT) serves as the primary site of energy storage, brown adipose tissue (BAT) instead metabolizes fat to produce heat and regulate body temperature. BAT is likely present in all humans, but the low prevalence of BAT depiction in adults and elderly subjects has hindered longitudinal assessments of the relation between BAT activity and WAT. Under typical imaging conditions, BAT is detected more frequently in children and teenagers than in adults with malignancy. Since most children with cancer have significantly shorter treatment courses and greater survival rates compared to adult patients, the investigators have the ability to examine the relation of repeated measures of body composition and BAT by selecting pediatric patients. In this study, the investigators will longitudinally examine whether BAT activity is related to changes in weight and the amounts of SAT, VAT, and abdominal muscle in children successfully treated for pediatric cancer.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Malignant Disease with no visualized BAT Children 18 years or younger who 1) had PET/CT scans with evidence of malignant disease but no metabolically active brown adipose tissue (BAT) at diagnosis and 2) were disease free within 1 year of diagnosis. |
Outcome Measures
Primary Outcome Measures
- Change from Baseline in Subcutaneous Adipose Tissue Volume at Follow-up [Baseline and up to 1 year]
- Change from Baseline in Visceral Adipose Tissue Volume at Follow-up [Baseline and up to 1 year]
- Change from Baseline in Presence of Brown Adipose Tissue [Baseline and up to 1 year]
- Change from Baseline in Abdominal Musculature Volume [Baseline and up to 1 year]
Secondary Outcome Measures
- Change from Baseline in Anthropometric Measures at Follow-up [Baseline and up to 1 year]
Age, height, weight and BMI
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients had PET/CT scans with evidence of malignant disease
-
Patients had no metabolically active BAT at diagnosis on their PET/CT scan
-
Patients were disease free within 1 year of diagnosis
Exclusion Criteria:
-
Patients had PET/CT scans with no evidence of malignant disease
-
Patients with metabolically active BAT at diagnosis on their PET/CT scan
-
Patients were not disease free within 1 year of diagnosis
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Children's Hospital Los Angeles | Los Angeles | California | United States | 90027-6062 |
Sponsors and Collaborators
- Children's Hospital Los Angeles
Investigators
- Principal Investigator: Vicente Gilsanz, MD, PhD, Children's Hospital Los Angeles
Study Documents (Full-Text)
None provided.More Information
Publications
- CHLA-Gilsanz-BAT/WAT